|Clinical Assistant Professor, Department of Pharmacy Practice
SIUE School of Pharmacy Psychiatry
|SIU School of MedicineDivision of Medicine Psychiatry|
|PGY-2 Psychiatric Pharmacy Practice Residency , 2009, University at Buffalo, The State University of New York, Buffalo, NY|
|PGY-1 General Practice Residency, Emphasis Psychiatry, 2008, University at Buffalo, The State University of New York, Buffalo, NY|
|Doctor of Pharmacy, 2007, Purdue University School of Pharmacy and Pharmaceutical Sciences, West Lafayette, IN|
My areas of clinical interest involve the treatment of severe and persistent mental illnesses, including schizophrenia and bipolar disorder, and management of comorbid medical conditions. I aim to communicate the fundamentals of psychopharmacology while serving as a role model for the empathetic approach towards caring for individuals challenged with mental illness. With the division of Medicine Psychiatry, my clinical interests have shifted towards the treatment of mentally ill chemical abusers, adjunct pharmacotherapy for prevention and management of psychiatric crisis situations, and drug-induced psychosis.
Practice Site Information
My current practice site is with the SIU School of Medicine, Division of Medicine Psychiatry, in Springfield, IL. Medicine Psychiatry is a branch of medicine that serves patients with problems at the interface of adult general medicine and adult psychiatry. My scope of practice encompasses patients with psychiatric, medical, and combined illness. By integrating didactic coursework with case-based teaching, I hope to foster critical thinking, facilitate the acquisition of life-long learning skills, and assist in the development of problem-solving strategies to navigate through the psychotropic-related situations pharmacists may encounter in their careers. My clinical practice includes modeling the ideology of maintaining hope for recovery and for the reduction of stigma against individuals challenged with mental illness.
My research interests include psychopharmacology, schizophrenia, delirium, medication adverse effects, and adjunctive pharmacotherapy and psychotherapy for prevention and management of psychiatric crisis situations.
Other Professional Activities
2006-Present American Society of Health-System Pharmacists (ASHP)
2007-Present College of Psychiatric and Neurologic Pharmacists (CPNP)
2007-Present National Alliance on Mental Illness (NAMI)
2008-2009 Chief Resident, University at Buffalo-SUNY, Pharmacy Residency and Fellowship Program
2005-2007 American Pharmacists Association - Academy of Student Pharmacists (APhA-ASP)
Professional Presentations & Publications
Bergman S, Ronald K, Gonzalez M, Ruscin JM. Pharmacotherapy Update 2009, Part I: Cardiology, Neurology, and Psychiatry. Annals of Long-Term Care. 2009; 17(12): 30-34.
Bergman S, Ronald K, Gonzalez M, Ruscin JM. Pharmacotherapy Update 2009, Part II: Infectious Disease, Positive Beers Criteria, and Pharmacist Interventions. Annals of Long-Term Care 2010; 18(2): 41-44.
Gonzalez M, Bellnier T, Demler T, Bingel S, Simon R. Cardiometabolic Impact of Atypical Antipsychotics: 10 Years Later. Journal of Pharmacy Practice 2009; 22(2) [abstract]. Poster Presentation at the College of Psychiatric and Neurologic Pharmacists - 2009 Annual Meeting.
Gonzalez M, Demler T, Bellnier T. Clozapine Treated Psychiatric Inpatients Post Smoking Cessation: Effect on Psychiatric Symptomatology. Journal of Pharmacy Practice 2008; 21(1) [abstract]. Poster Presentation at the College of Psychiatric and Neurologic Pharmacists - 2008 Annual Meeting.